Premium
The emerging role of miR‐375 in cancer
Author(s) -
Yan JunWei,
Lin JuSheng,
He XingXing
Publication year - 2013
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.28563
Subject(s) - microrna , biology , carcinogenesis , pancreatic cancer , cancer research , cancer , yap1 , gene silencing , transcription factor , dna methylation , gene expression , gene , genetics
MicroRNAs (miRNAs) are evolutionarily conserved, small noncoding RNAs that are believed to play fundamental roles in various biological processes through regulation of gene expression at the level of posttranscription. MiR‐375 was first identified as a pancreatic islet‐specific miRNA regulating insulin secretion. However, further study revealed that miR‐375 is a multifunctional miRNA participating in pancreatic islet development, glucose homeostasis, mucosal immunity, lung surfactant secretion and more importantly, tumorigenesis. Recently, miR‐375 has been found significantly downregulated in multiple types of cancer, and suppresses core hallmarks of cancer by targeting several important oncogenes like AEG‐1 , YAP1 , IGF1R and PDK1 . The alteration of miR‐375 in cancer is caused by a variety of mechanisms, including the dysregulation of transcription factors, aberrant promoter methylation and so on. Reduced expression of miR‐375 in tissue or circulation may indicate the presence of neoplasia as well as a poor prognosis of many malignant cancers. Moreover, miR‐375 stands for a promising direction for developing targeted therapies due to its capacity to inhibit tumor cell growth in vitro and in vivo . Here, we summarize the present understanding of the tumor suppressive role of miR‐375 in cancer progression; the mechanisms underlying the dysregulation of miR‐375; the potential use of miR‐375 in prognosis and diagnosis and the therapeutic prospects of miR‐375 in cancer.